• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA OKs World's First Single-Use Duodenoscope

    Dr. Stephen Hahn Confirmed as New FDA Leader

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    MedStar Health and Cleveland Clinic Innovations Awarded Grant

    3M to Sell Drug Delivery Business for $650M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    GS Plastic Optics

    RJG Inc.

    Marox Corporation

    Nelson Laboratories LLC

    Accumold
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EU's MDR: Irresistible Force Meets Immovable Object

    Ladies First: An Examination of the Women's Health Device Industry

    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    RJG Inc.

    Nelson Laboratories LLC

    Glenbrook Technologies Inc.

    Carclo Technical Plastics

    Accumold
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Second Sight Gets German Approval to Begin Argus II Study

    Trial will measure the improvement of the visual field added by the Argus II for RP patients with tunnel vision.

    Related CONTENT
    • Competition Seeks Development of Human Eye Tissue in a Dish
    • Ph.D. Student Invents First Synthetic Retina for Visually Impaired
    • Wearable System Helps Visually Impaired Users Navigate
    • Second Sight Announces Market Entry into Russia with First Implant of Argus II
    • First Patient in the Nation Receives a Telescope Implant for Age-Related Macular Degeneration
    Business Wire11.03.17
    Second Sight Medical Products Inc., a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, has received approval from Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), the German competent authority, and a favorable opinion by the applicable ethics committees, to begin a 10-patient study in Germany to implant and evaluate the Argus II Retinal Prosthesis System (Argus II) in better sighted retinitis pigmentosa (RP) patients, or those individuals who have some “tunnel vision.” Tunnel vision is a condition defined by a visual field that is severely constricted.
     
    The clinical study will be conducted with lead principal investigators at three sites in Germany as follows: Universitätsklinikum Aachen with Professor Walter, Städtisches Klinikum Kalrsruhe with Professor Augustin, and Universitätsklinikum Schleswig-Holstein, Universitätsklinikum Lübeck with Professsor Grisanti. The primary endpoint of the study is to measure the improvement of the visual field added by the Argus II for RP patients with tunnel vision. A secondary endpoint will be to evaluate how well those treated with the Argus II integrate the system into their daily lives.
     
    “This is an important study and part of our strategy to evaluate the Argus II in better sighted individuals. We are excited by the opportunity to potentially improve the functional vision of additional blind individuals suffering from RP and look forward to initiating enrollment by the end of this year. If successful, the targeted population could increase the potential market for the Argus II by two to three times its current size,” stated Will McGuire, president and CEO of Second Sight.
     
    Professor Walter, Universitätsklinikum Aachen, commented, “This study has the potential to change the management of patients with RP and, if successful, greatly expand the patient population who can benefit from this treatment, and for whom the Argus II could be a solution.”
     
    Second Sight's Argus II System provides electrical stimulation that bypasses the defunct retinal cells and stimulates remaining viable cells inducing visual perception in individuals with severe to profound Retinitis Pigmentosa. The Argus II works by converting images captured by a miniature video camera mounted on the patient's glasses into a series of small electrical pulses, which are transmitted wirelessly to an array of electrodes implanted on the surface of the retina. These pulses stimulate the retina's remaining cells, intending to result in the perception of patterns of light in the brain. The patient must learn to interpret these visual patterns, having the potential to regain some visual function. The Argus II was the first artificial retina to receive widespread commercial approval, and is offered at approved centers in Canada, France, Germany, Italy, Russia, Saudi Arabia, South Korea, Spain, Taiwan, Turkey, the United Kingdom, and the United States.
     
    Second Sight's mission is to develop, manufacture and market implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight has developed, and now manufactures and markets, the Argus II Retinal Prosthesis System. Enrollment has been completed in a feasibility trial to test the safety and utility of the Argus II in individuals with dry age-related macular degeneration. Second Sight is also developing the Orion Visual Cortical Prosthesis to restore some vision to individuals who are blind due to causes other than preventable or treatable conditions. The company's U.S. headquarters is in Sylmar, Calif., and its European headquarters is in Lausanne, Switzerland.
    Related Searches
    • ceo
    • brain
    • visual function
    • change
    Suggested For You
    First Patient in the Nation Receives a Telescope Implant for Age-Related Macular Degeneration First Patient in the Nation Receives a Telescope Implant for Age-Related Macular Degeneration
    Second Sight Announces Market Entry into Russia with First Implant of Argus II Second Sight Announces Market Entry into Russia with First Implant of Argus II
    Wearable System Helps Visually Impaired Users Navigate Wearable System Helps Visually Impaired Users Navigate
    Ph.D. Student Invents First Synthetic Retina for Visually Impaired Ph.D. Student Invents First Synthetic Retina for Visually Impaired
    Competition Seeks Development of Human Eye Tissue in a Dish Competition Seeks Development of Human Eye Tissue in a Dish

    Related Breaking News

    • Surgical
      FDA OKs World

      FDA OKs World's First Single-Use Duodenoscope

      Boston Scientific's EXALT Model D Duodenoscope eliminates the need for duodenoscope reprocessing and repairs,
      PR Newswire 12.13.19

    • Dr. Stephen Hahn Confirmed as New FDA Leader

      Dr. Stephen Hahn Confirmed as New FDA Leader

      He has never worked in a government position, so his potential FDA agenda is currently unknown.
      Sam Brusco, Associate Editor 12.13.19

    • Diagnostics
      FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

      FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

      PerkinElmer's test measures dried blood samples collected from the prick of a newborn’s heel 24 to 48 hours after birth.
      U.S. Food and Drug Administration 12.13.19


    • Contract Manufacturing | R&D & Design
      MedStar Health and Cleveland Clinic Innovations Awarded Grant

      MedStar Health and Cleveland Clinic Innovations Awarded Grant

      Cool Idea Award from Protolabs spurs innovation.
      Protolabs 12.12.19

    • 3M to Sell Drug Delivery Business for $650M

      3M to Sell Drug Delivery Business for $650M

      The business, which has annual sales of about $380 million, is being sold to an affiliate of Altaris Capital Partners.
      Business Wire 12.12.19

    • Neurological
      First U.S. Patient Implanted With Axonics

      First U.S. Patient Implanted With Axonics' Sacral Neuromodulation System

      The Axonics r-SNM System is approximately the size of a USB stick and is qualified to operate for at least 15 years.
      Businesswire 12.12.19


    • Cardiovascular
      First U.S. Patients Treated With a Minimally Invasive, Forward Flow Heart Pump

      First U.S. Patients Treated With a Minimally Invasive, Forward Flow Heart Pump

      Impella 5.5 with SmartAssist delivers peak flows of greater than six liters per minute.
      Businesswire 12.12.19

    • Digital Health
      New Pocket Ultrasound Scanners Smaller, More Powerful, and More Affordable

      New Pocket Ultrasound Scanners Smaller, More Powerful, and More Affordable

      Easier to use, second-generation ultra portable wireless scanners give doctors a clearer picture of what's going on.
      PR Newswire 12.12.19

    • Digital Health | Software & IT
      15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results

      15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results

      Florida’s first eICU, powered by Philips telehealth technology, touts reduced mortality rates and hospital stays for the sickest patients.
      GlobeNewswire 12.11.19


    • 3D/Additive Manufacturing | Software & IT
      Prellis Biologics

      Prellis Biologics' New Tool Simplifies Complex Tissue Engineering

      TissueWorkshop generates complex 3D scaffolds that can be printed with any 3D printing system.
      Krause Taylor Associates 12.11.19

    • InspireMD

      InspireMD's CEO Steps Down

      New CEO Marvin Slosman, a life sciences industry veteran, joins InspireMD from Integra LifeSciences.
      GlobeNewswire 12.11.19

    • Celmatix Sues Research Partner 23andMe for $100M

      Celmatix Sues Research Partner 23andMe for $100M

      Celmatix claims breaches of the parties' agreement and tortious interference with efforts to raise capital.
      PR Newswire 12.11.19

    • FDA Cleared New Cochlear Osia 2 System

      FDA Cleared New Cochlear Osia 2 System

      The world’s first active osseointegrated steady-state implant.
      Cochlear 12.11.19

    • Neurological
      FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity

      FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity

      Aptar’s Unidose Liquid System can deliver a formulation in an emergency situation quickly and easily and be administered by a non-healthcare professional.
      Business Wire 12.10.19

    • Diagnostics
      Lens-Free Microendoscope Generates High Quality Images

      Lens-Free Microendoscope Generates High Quality Images

      It also doesn't require movement to focus on objects at different depths.
      Johns Hopkins University 12.10.19


    Breaking News
    • FDA OKs World's First Single-Use Duodenoscope
    • Dr. Stephen Hahn Confirmed as New FDA Leader
    • FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    • MedStar Health and Cleveland Clinic Innovations Awarded Grant
    • 3M to Sell Drug Delivery Business for $650M
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.